Hematological Oncology Cancer Research

Adjusted Indirect Comparison Between Epcoritamab‐R2 and Tafasitamab‐R2 in Relapse/Refractory Follicular Lymphoma

Leonidas Benetatos, Elisavet Apostolidou, Vasileios Georgoulis, Georgios S. Markopoulos, Savvas Dimitriadis, Eleftheria Hatzimichael, Eleni Kapsali
Wiley · 2026-10-24 · DOI 10.1002/hon.70282
⬢ Cited by: 0 Crossref

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →